Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
The Journal of Pathology. Clinical Research
|
October 13, 2019
Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes
Hilde Ytre-Hauge Smeland, Cecilie Askeland, Elisabeth Wik, et al.
Rheumatology International
|
May 4, 2021
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort
Johanna E Gehin, Rolf A Klaasen, Ellen S Norli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 10, 2024
The Prevalence and Rate of Undiagnosed Celiac Disease in an Adult General Population, the Trøndelag Health Study, Norway
Polina Lukina, Ina L Andersen, Rolf A Klaasen, et al.
Therapeutic Drug Monitoring
|
February 2, 2026
The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial
Johanna E Gehin, Rolf A Klaasen, Eirik K Kristianslund, et al.
Scientific Reports
|
June 3, 2021
BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors
Borja Hernández-Breijo, Victoria Navarro-Compán, Chamaida Plasencia-Rodríguez, et al.
United European Gastroenterology Journal
|
October 20, 2020
Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease
Ana-Marija Grišić, Maria Dorn-Rasmussen, Bella Ungar, et al.
BMJ Neurology Open
|
March 25, 2026
Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumab
Einar August Høgestøl, Åge Winje Brustad, Elisabeth Gulowsen Celius, et al.
Trials
|
January 8, 2020
Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study)
Silje W Syversen, Guro L Goll, Kristin K Jørgensen, et al.
BMJ Open
|
January 9, 2024
Coeliac disease in the Trøndelag Health Study (HUNT), Norway, a population-based cohort of coeliac disease patients
Polina Lukina, Ina Lervåg Andersen, Petter Tinbod Eggen, et al.
Journal for Immunotherapy of Cancer
|
April 11, 2024
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
Nicholas P Casey, Katrin Kleinmanns, Christopher Forcados, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
The Journal of Pathology. Clinical Research
|
October 13, 2019
Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes
Hilde Ytre-Hauge Smeland, Cecilie Askeland, Elisabeth Wik, et al.
Rheumatology International
|
May 4, 2021
Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort
Johanna E Gehin, Rolf A Klaasen, Ellen S Norli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 10, 2024
The Prevalence and Rate of Undiagnosed Celiac Disease in an Adult General Population, the Trøndelag Health Study, Norway
Polina Lukina, Ina L Andersen, Rolf A Klaasen, et al.
Therapeutic Drug Monitoring
|
February 2, 2026
The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial
Johanna E Gehin, Rolf A Klaasen, Eirik K Kristianslund, et al.
Scientific Reports
|
June 3, 2021
BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors
Borja Hernández-Breijo, Victoria Navarro-Compán, Chamaida Plasencia-Rodríguez, et al.
United European Gastroenterology Journal
|
October 20, 2020
Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease
Ana-Marija Grišić, Maria Dorn-Rasmussen, Bella Ungar, et al.
BMJ Neurology Open
|
March 25, 2026
Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumab
Einar August Høgestøl, Åge Winje Brustad, Elisabeth Gulowsen Celius, et al.
Trials
|
January 8, 2020
Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study)
Silje W Syversen, Guro L Goll, Kristin K Jørgensen, et al.
BMJ Open
|
January 9, 2024
Coeliac disease in the Trøndelag Health Study (HUNT), Norway, a population-based cohort of coeliac disease patients
Polina Lukina, Ina Lervåg Andersen, Petter Tinbod Eggen, et al.
Journal for Immunotherapy of Cancer
|
April 11, 2024
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
Nicholas P Casey, Katrin Kleinmanns, Christopher Forcados, et al.
Page
of 9